OKYO PHARMA LTD (OKYO)

GG00BMFG5F62 - Common Stock

1.0321  +0 (+0.2%)

After market: 1.094 +0.06 (+6%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
N/AN/A
EBITDA
YoY % growth
-20.16M-3.48M
82.74%		-1.21M
65.23%		-2.56M
-111.57%		-4.55M
-77.73%		-10.935M
-140.34%		N/AN/A
EBIT
YoY % growth
-20.16M-3.48M
82.74%		-1.21M
65.23%		-2.57M
-112.40%		-4.55M
-77.04%		-10.939M
-140.41%		N/A
-9.10%		N/A
-28.63%
Operating Margin
N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
N/AN/AN/AN/AN/AN/AN/A
-4,543.98%		N/A
5.00%

All data in GBP

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.10-0.09-0.09
18.18%		-0.09
18.18%		-0.10-0.10
-11.11%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-2.958M-3.06M
52.06%		N/AN/AN/AN/A

All data in GBP

Recent Earnings VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (GBP)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
RevenueN/A N/A N/A N/A